Saravia NG - Search Results

1

Resistance to oxidative stress is associated with metastasis in mucocutaneous leishmaniasis.

Acestor N, Masina S, Ives A, Walker J, Saravia NG, Fasel N. Acestor N, et al. Among authors: saravia ng. J Infect Dis. 2006 Oct 15;194(8):1160-7. doi: 10.1086/507646. Epub 2006 Sep 8. J Infect Dis. 2006. PMID: 16991092

2

mHealth Monitoring of Treatment of Cutaneous Leishmaniasis Patients: A Community-Based Implementation Study.

Cossio A, Bautista-Gomez MM, Alexander N, Del Castillo AM, Castro MDM, Castaño-Grajales PY, Gutiérrez-Poloche YH, Zuluaga LS, Vargas-Bernal L, Navarro A, Saravia NG. Cossio A, et al. Among authors: saravia ng. Am J Trop Med Hyg. 2023 Aug 28;109(4):778-790. doi: 10.4269/ajtmh.22-0805. Print 2023 Oct 4. Am J Trop Med Hyg. 2023. PMID: 37640290 Free PMC article.

3

Establishing two-dimensional gels for the analysis of Leishmania proteomes.

Acestor N, Masina S, Walker J, Saravia NG, Fasel N, Quadroni M. Acestor N, et al. Among authors: saravia ng. Proteomics. 2002 Jul;2(7):877-9. doi: 10.1002/1615-9861(200207)2:7<877::AID-PROT877>3.0.CO;2-D. Proteomics. 2002. PMID: 12124933

4

Mapping the proteome of Leishmania Viannia parasites using two-dimensional polyacrylamide gel electrophoresis and associated technologies.

Góngora R, Acestor N, Quadroni M, Fasel N, Saravia NG, Walker J. Góngora R, et al. Among authors: saravia ng. Biomedica. 2003 Jun;23(2):153-60. Biomedica. 2003. PMID: 12872554

5

Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.

Walker J, Saravia NG. Walker J, et al. Among authors: saravia ng. J Parasitol. 2004 Oct;90(5):1155-62. doi: 10.1645/GE-3347. J Parasitol. 2004. PMID: 15562618

6

Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.

Saravia NG, Hazbón MH, Osorio Y, Valderrama L, Walker J, Santrich C, Cortázar T, Lebowitz JH, Travi BL. Saravia NG, et al. Vaccine. 2005 Jan 11;23(8):984-95. doi: 10.1016/j.vaccine.2004.07.044. Vaccine. 2005. PMID: 15620471

7

Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction.

Vergel C, Walker J, Saravia NG. Vergel C, et al. Among authors: saravia ng. Am J Trop Med Hyg. 2005 Apr;72(4):423-9. Am J Trop Med Hyg. 2005. PMID: 15827280

8

Comparative protein profiling identifies elongation factor-1beta and tryparedoxin peroxidase as factors associated with metastasis in Leishmania guyanensis.

Walker J, Acestor N, Gongora R, Quadroni M, Segura I, Fasel N, Saravia NG. Walker J, et al. Among authors: saravia ng. Mol Biochem Parasitol. 2006 Feb;145(2):254-64. doi: 10.1016/j.molbiopara.2005.10.008. Epub 2005 Oct 28. Mol Biochem Parasitol. 2006. PMID: 16325936

9

Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.

Romero IC, Saravia NG, Walker J. Romero IC, et al. Among authors: saravia ng. J Parasitol. 2005 Dec;91(6):1474-9. doi: 10.1645/GE-3489.1. J Parasitol. 2005. PMID: 16539034

10

Evidence for leishmania (viannia) parasites in the skin and blood of patients before and after treatment.

Vergel C, Palacios R, Cadena H, Posso CJ, Valderrama L, Perez M, Walker J, Travi BL, Saravia NG. Vergel C, et al. Among authors: saravia ng. J Infect Dis. 2006 Aug 15;194(4):503-11. doi: 10.1086/505583. Epub 2006 Jul 10. J Infect Dis. 2006. PMID: 16845635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters